Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.

Robinson JO, Wynn J, Biesecker B, Biesecker LG, Bernhardt B, Brothers KB, Chung WK, Christensen KD, Green RC, McGuire AL, Hart MR, Griesemer I, Patrick DL, Rini C, Veenstra D, Cronin AM, Gray SW.

Genet Med. 2019 Jun 13. doi: 10.1038/s41436-019-0565-3. [Epub ahead of print]

PMID:
31189963
2.

Phenotypic Characterization of Individuals With Variants in Cardiovascular Genes in the Absence of a Primary Cardiovascular Indication for Testing.

Hylind RJ, Chandler SF, Beausejour Ladouceur V, Roberts AE, Bezzerides V, Christensen KD, Coggins M, Lakdawala NK, MacRae CA, Abrams DJ.

Circ Genom Precis Med. 2019 Mar;12(3):e002463. doi: 10.1161/CIRCGEN.119.002463. No abstract available.

PMID:
30919684
3.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Sagardia AM, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA.

Genet Med. 2019 May;21(5):1261-1262. doi: 10.1038/s41436-019-0440-2.

PMID:
30670880
4.

The utility of infrared thermography for evaluating lameness attributable to bacterial chondronecrosis with osteomyelitis.

Weimer SL, Wideman RF, Scanes CG, Mauromoustakos A, Christensen KD, Vizzier-Thaxton Y.

Poult Sci. 2019 Apr 1;98(4):1575-1588. doi: 10.3382/ps/pey538.

PMID:
30508160
5.

Communication Predictors of Patient and Companion Satisfaction with Alzheimer's Genetic Risk Disclosure.

Guan Y, Roter DL, Erby LH, Wolff JL, Gitlin LN, Roberts JS, Green RC, Christensen KD.

J Health Commun. 2018;23(8):807-814. doi: 10.1080/10810730.2018.1528319.

6.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Miren Sagardia A, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA.

Genet Med. 2019 May;21(5):1100-1110. doi: 10.1038/s41436-018-0308-x. Epub 2018 Oct 5. Erratum in: Genet Med. 2019 Jan 22;:.

PMID:
30287922
7.

Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project.

Christensen KD, Phillips KA, Green RC, Dukhovny D.

Value Health. 2018 Sep;21(9):1054-1061. doi: 10.1016/j.jval.2018.06.013. Epub 2018 Aug 14.

PMID:
30224109
8.

Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.

Phillips KA, Deverka PA, Marshall DA, Wordsworth S, Regier DA, Christensen KD, Buchanan J.

Value Health. 2018 Sep;21(9):1033-1042. doi: 10.1016/j.jval.2018.06.017. Epub 2018 Aug 8. Review. Erratum in: Value Health. 2019 Mar;22(3):383.

9.

The BabySeq project: implementing genomic sequencing in newborns.

Holm IA, Agrawal PB, Ceyhan-Birsoy O, Christensen KD, Fayer S, Frankel LA, Genetti CA, Krier JB, LaMay RC, Levy HL, McGuire AL, Parad RB, Park PJ, Pereira S, Rehm HL, Schwartz TS, Waisbren SE, Yu TW; BabySeq Project Team, Green RC, Beggs AH.

BMC Pediatr. 2018 Jul 9;18(1):225. doi: 10.1186/s12887-018-1200-1.

10.

An evaluation of methods for measuring stress in broiler chickens.

Weimer SL, Wideman RF, Scanes CG, Mauromoustakos A, Christensen KD, Vizzier-Thaxton Y.

Poult Sci. 2018 Oct 1;97(10):3381-3389. doi: 10.3382/ps/pey204.

PMID:
29901761
11.

Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.

Christensen KD, Vassy JL, Phillips KA, Blout CL, Azzariti DR, Lu CY, Robinson JO, Lee K, Douglas MP, Yeh JM, Machini K, Stout NK, Rehm HL, McGuire AL, Green RC, Dukhovny D; MedSeq Project.

Genet Med. 2018 Dec;20(12):1544-1553. doi: 10.1038/gim.2018.35. Epub 2018 Mar 22.

12.

Enhancing Autonomy in Biobank Decisions: Too Much of a Good Thing?

Mitchell PB, Ziniel SI, Savage SK, Christensen KD, Weitzman ER, Green RC, Huntington NL, Mathews DJ, Holm IA.

J Empir Res Hum Res Ethics. 2018 Apr;13(2):125-138. doi: 10.1177/1556264617753483. Epub 2018 Feb 23.

PMID:
29471711
13.

Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings.

Christensen KD, Bernhardt BA, Jarvik GP, Hindorff LA, Ou J, Biswas S, Powell BC, Grundmeier RW, Machini K, Karavite DJ, Pennington JW, Krantz ID, Berg JS, Goddard KAB.

Genet Med. 2018 Oct;20(10):1186-1195. doi: 10.1038/gim.2017.243. Epub 2018 Feb 1.

14.

Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project.

Roberts JS, Robinson JO, Diamond PM, Bharadwaj A, Christensen KD, Lee KB, Green RC, McGuire AL; MedSeq Project team.

Genet Med. 2018 Sep;20(9):1069-1076. doi: 10.1038/gim.2017.223. Epub 2018 Jan 4.

15.

The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease.

Guan Y, Roter DL, Wolff JL, Gitlin LN, Christensen KD, Roberts JS, Green RC, Erby LH.

Patient Educ Couns. 2018 May;101(5):817-823. doi: 10.1016/j.pec.2017.11.019. Epub 2017 Nov 27.

16.

When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.

Jamal L, Robinson JO, Christensen KD, Blumenthal-Barby J, Slashinski MJ, Perry DL, Vassy JL, Wycliff J, Green RC, McGuire AL.

AJOB Empir Bioeth. 2017 Apr-Jun;8(2):82-88. doi: 10.1080/23294515.2017.1287786. Epub 2017 Jan 27.

PMID:
28949844
17.

Effects of bacitracin methylene disalicylate and diet change on gastrointestinal integrity and endotoxin permeability in the duodenum of broiler chicken.

Koltes DA, Lester HD, Frost M, Aldridge D, Christensen KD, Scanes CG.

BMC Res Notes. 2017 Sep 8;10(1):470. doi: 10.1186/s13104-017-2781-8.

18.

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.

Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC.

Genet Med. 2018 Jan;20(1):132-141. doi: 10.1038/gim.2017.103. Epub 2017 Jul 20.

19.

The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.

Vassy JL, Christensen KD, Schonman EF, Blout CL, Robinson JO, Krier JB, Diamond PM, Lebo M, Machini K, Azzariti DR, Dukhovny D, Bates DW, MacRae CA, Murray MF, Rehm HL, McGuire AL, Green RC; MedSeq Project.

Ann Intern Med. 2017 Jun 27;167(3):159-169. doi: 10.7326/M17-0188. Print 2017 Aug 1.

20.

Preferences for the Return of Individual Results From Research on Pediatric Biobank Samples.

Christensen KD, Savage SK, Huntington NL, Weitzman ER, Ziniel SI, Bacon PL, Cacioppo CN, Green RC, Holm IA.

J Empir Res Hum Res Ethics. 2017 Apr;12(2):97-106. doi: 10.1177/1556264617697839.

21.

Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study.

Guan Y, Roter DL, Erby LH, Wolff JL, Gitlin LN, Roberts JS, Green RC, Christensen KD.

Patient Educ Couns. 2017 May;100(5):927-935. doi: 10.1016/j.pec.2016.12.005. Epub 2016 Dec 14.

22.

Family health history reporting is sensitive to small changes in wording.

Conway-Pearson LS, Christensen KD, Savage SK, Huntington NL, Weitzman ER, Ziniel SI, Bacon P, Cacioppo CN, Green RC, Holm IA.

Genet Med. 2016 Dec;18(12):1308-1311. doi: 10.1038/gim.2016.45. Epub 2016 May 5.

23.

Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project.

Lupo PJ, Robinson JO, Diamond PM, Jamal L, Danysh HE, Blumenthal-Barby J, Lehmann LS, Vassy JL, Christensen KD, Green RC, McGuire AL; MedSeq Project team.

Per Med. 2016 Jan 1;13(1):13-20. Epub 2016 Jan 8.

24.

Symposium: Animal welfare challenges for today and tomorrow.

Vizzier Thaxton Y, Christensen KD, Mench JA, Rumley ER, Daugherty C, Feinberg B, Parker M, Siegel P, Scanes CG.

Poult Sci. 2016 Sep 1;95(9):2198-207. doi: 10.3382/ps/pew099. Epub 2016 Mar 18.

PMID:
26994205
25.

Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing.

Robinson JO, Carroll TM, Feuerman LZ, Perry DL, Hoffman-Andrews L, Walsh RC, Christensen KD, Green RC, McGuire AL; MedSeq Project Team.

J Empir Res Hum Res Ethics. 2016 Feb;11(1):21-30. doi: 10.1177/1556264615624078. Epub 2016 Feb 28.

26.

Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees.

Baptista NM, Christensen KD, Carere DA, Broadley SA, Roberts JS, Green RC.

Genet Med. 2016 Sep;18(9):924-32. doi: 10.1038/gim.2015.192. Epub 2016 Jan 28.

27.

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.

Christensen KD, Roberts JS, Whitehouse PJ, Royal CD, Obisesan TO, Cupples LA, Vernarelli JA, Bhatt DL, Linnenbringer E, Butson MB, Fasaye GA, Uhlmann WR, Hiraki S, Wang N, Cook-Deegan R, Green RC; REVEAL Study Group*.

Ann Intern Med. 2016 Feb 2;164(3):155-63. doi: 10.7326/M15-0187. Epub 2016 Jan 26.

28.

Assessing the Costs and Cost-Effectiveness of Genomic Sequencing.

Christensen KD, Dukhovny D, Siebert U, Green RC.

J Pers Med. 2015 Dec 10;5(4):470-86. doi: 10.3390/jpm5040470. Review.

29.

Participant Satisfaction With a Preference-Setting Tool for the Return of Individual Research Results in Pediatric Genomic Research.

Holm IA, Iles BR, Ziniel SI, Bacon PL, Savage SK, Christensen KD, Weitzman ER, Green RC, Huntington NL.

J Empir Res Hum Res Ethics. 2015 Oct;10(4):414-26. doi: 10.1177/1556264615599620.

PMID:
26376753
30.

Are physicians prepared for whole genome sequencing? a qualitative analysis.

Christensen KD, Vassy JL, Jamal L, Lehmann LS, Slashinski MJ, Perry DL, Robinson JO, Blumenthal-Barby J, Feuerman LZ, Murray MF, Green RC, McGuire AL; MedSeq Project Team.

Clin Genet. 2016 Feb;89(2):228-34. doi: 10.1111/cge.12626. Epub 2015 Jul 7.

31.

A systematic approach to the reporting of medically relevant findings from whole genome sequencing.

McLaughlin HM, Ceyhan-Birsoy O, Christensen KD, Kohane IS, Krier J, Lane WJ, Lautenbach D, Lebo MS, Machini K, MacRae CA, Azzariti DR, Murray MF, Seidman CE, Vassy JL, Green RC, Rehm HL; MedSeq Project.

BMC Med Genet. 2014 Dec 14;15:134. doi: 10.1186/s12881-014-0134-1.

32.

Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction.

Robinson CL, Jouni H, Kruisselbrink TM, Austin EE, Christensen KD, Green RC, Kullo IJ.

Clin Genet. 2016 Feb;89(2):251-7. doi: 10.1111/cge.12577. Epub 2015 Mar 23.

PMID:
25708169
33.

Associations between self-referral and health behavior responses to genetic risk information.

Christensen KD, Roberts JS, Zikmund-Fisher BJ, Kardia SL, McBride CM, Linnenbringer E, Green RC; REVEAL Study Group.

Genome Med. 2015 Jan 31;7(1):10. doi: 10.1186/s13073-014-0124-0. eCollection 2015.

34.

'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.

Vassy JL, Christensen KD, Slashinski MJ, Lautenbach DM, Raghavan S, Robinson JO, Blumenthal-Barby J, Feuerman LZ, Lehmann LS, Murray MF, Green RC, McGuire AL.

Per Med. 2015;12(1):23-32.

35.

Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study.

Besser AG, Sanderson SC, Roberts JS, Chen CA, Christensen KD, Lautenbach DM, Cupples LA, Green RC.

Public Health Genomics. 2015;18(2):78-86. doi: 10.1159/000368888. Epub 2015 Jan 24.

36.

Erratum to: How can psychological science inform research about genetic counseling for clinical genomic sequencing?

Khan CM, Rini C, Bernhardt BA, Roberts JS, Christensen KD, Evans JP, Brothers KB, Roche MI, Berg JS, Henderson GE.

J Genet Couns. 2015 Apr;24(2):372. doi: 10.1007/s10897-014-9814-4.

37.

A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.

Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CD, Obisesan TO, Cook-Deegan R, Linnenbringer E, Butson MB, Fasaye GA, Levinson E, Roberts JS; REVEAL Study Group.

Alzheimers Dement. 2015 Oct;11(10):1222-30. doi: 10.1016/j.jalz.2014.10.014. Epub 2014 Dec 9.

38.

How can psychological science inform research about genetic counseling for clinical genomic sequencing?

Khan CM, Rini C, Bernhardt BA, Roberts JS, Christensen KD, Evans JP, Brothers KB, Roche MI, Berg JS, Henderson GE.

J Genet Couns. 2015 Apr;24(2):193-204. doi: 10.1007/s10897-014-9804-6. Epub 2014 Dec 9. Erratum in: J Genet Couns. 2015 Apr;24(2):372.

39.

The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.

Vassy JL, Lautenbach DM, McLaughlin HM, Kong SW, Christensen KD, Krier J, Kohane IS, Feuerman LZ, Blumenthal-Barby J, Roberts JS, Lehmann LS, Ho CY, Ubel PA, MacRae CA, Seidman CE, Murray MF, McGuire AL, Rehm HL, Green RC; MedSeq Project.

Trials. 2014 Mar 20;15:85. doi: 10.1186/1745-6215-15-85.

40.

Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group.

Gray SW, Martins Y, Feuerman LZ, Bernhardt BA, Biesecker BB, Christensen KD, Joffe S, Rini C, Veenstra D, McGuire AL; CSER Consortium Outcomes and Measures Working Group.

Genet Med. 2014 Oct;16(10):727-35. doi: 10.1038/gim.2014.26. Epub 2014 Mar 13. Review.

41.

How could disclosing incidental information from whole-genome sequencing affect patient behavior?

Christensen KD, Green RC.

Per Med. 2013 Jun;10(4). doi: 10.2217/pme.13.24.

42.

[Videocapsule endoscopy used for diagnosis of Henoch-Schönlein purpura with gastrointestinal complications].

Sivayogajeyam S, Christensen KD.

Ugeskr Laeger. 2013 Sep 16;175(38):2195-6. Danish.

PMID:
24044543
43.

Communicating genetic risk information for common disorders in the era of genomic medicine.

Lautenbach DM, Christensen KD, Sparks JA, Green RC.

Annu Rev Genomics Hum Genet. 2013;14:491-513. doi: 10.1146/annurev-genom-092010-110722. Review.

44.

Successful isolated intestinal transplantation in sensitized recipients with the use of virtual crossmatching.

Hawksworth JS, Rosen-Bronson S, Island E, Girlanda R, Guerra JF, Valdiconza C, Kishiyama K, Christensen KD, Kozlowski S, Kaufman S, Little C, Shetty K, Laurin J, Satoskar R, Kallakury B, Fishbein TM, Matsumoto CS.

Am J Transplant. 2012 Dec;12 Suppl 4:S33-42. doi: 10.1111/j.1600-6143.2012.04238.x. Epub 2012 Sep 4.

45.

Community engagement about genetic variation research.

Terry SF, Christensen KD, Metosky S, Rudofsky G, Deignan KP, Martinez H, Johnson-Moore P, Citrin T.

Popul Health Manag. 2012 Apr;15(2):78-89. doi: 10.1089/pop.2011.0013. Epub 2011 Aug 4.

46.

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.

Roberts JS, Christensen KD, Green RC.

Clin Genet. 2011 Nov;80(5):407-14. doi: 10.1111/j.1399-0004.2011.01739.x. Epub 2011 Jul 18. Review.

47.

Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.

Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SY, Raskin L, Gruber SB.

Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):522-9. doi: 10.1158/1055-9965.EPI-10-1045. Epub 2011 Feb 9.

48.

Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.

Christensen KD, Roberts JS, Uhlmann WR, Green RC.

Genet Med. 2011 May;13(5):409-14. doi: 10.1097/GIM.0b013e3182076bf1.

49.

Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs.

Hock KT, Christensen KD, Yashar BM, Roberts JS, Gollust SE, Uhlmann WR.

Genet Med. 2011 Apr;13(4):325-32. doi: 10.1097/GIM.0b013e3182011636.

50.

Returning individual research results: development of a cancer genetics education and risk communication protocol.

Roberts JS, Shalowitz DI, Christensen KD, Everett JN, Kim SY, Raskin L, Gruber SB.

J Empir Res Hum Res Ethics. 2010 Sep;5(3):17-30. doi: 10.1525/jer.2010.5.3.17.

Supplemental Content

Loading ...
Support Center